Structure

Physi-Chem Properties

Molecular Weight:  582.23
Volume:  598.625
LogP:  5.638
LogD:  4.009
LogS:  -4.672
# Rotatable Bonds:  7
TPSA:  125.68
# H-Bond Aceptor:  8
# H-Bond Donor:  4
# Rings:  6
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.186
Synthetic Accessibility Score:  4.132
Fsp3:  0.286
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.904
MDCK Permeability:  1.0538608876231592e-05
Pgp-inhibitor:  0.034
Pgp-substrate:  0.045
Human Intestinal Absorption (HIA):  0.01
20% Bioavailability (F20%):  0.15
30% Bioavailability (F30%):  0.996

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.032
Plasma Protein Binding (PPB):  99.2936782836914%
Volume Distribution (VD):  0.307
Pgp-substrate:  1.3736852407455444%

ADMET: Metabolism

CYP1A2-inhibitor:  0.094
CYP1A2-substrate:  0.665
CYP2C19-inhibitor:  0.965
CYP2C19-substrate:  0.093
CYP2C9-inhibitor:  0.956
CYP2C9-substrate:  0.991
CYP2D6-inhibitor:  0.752
CYP2D6-substrate:  0.91
CYP3A4-inhibitor:  0.681
CYP3A4-substrate:  0.627

ADMET: Excretion

Clearance (CL):  12.899
Half-life (T1/2):  0.338

ADMET: Toxicity

hERG Blockers:  0.241
Human Hepatotoxicity (H-HT):  0.607
Drug-inuced Liver Injury (DILI):  0.948
AMES Toxicity:  0.368
Rat Oral Acute Toxicity:  0.977
Maximum Recommended Daily Dose:  0.993
Skin Sensitization:  0.957
Carcinogencity:  0.416
Eye Corrosion:  0.003
Eye Irritation:  0.821
Respiratory Toxicity:  0.717

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC1796

Natural Product ID:  NPC1796
Common Name*:   Calyxin K
IUPAC Name:   7-hydroxy-2-(4-hydroxyphenyl)-8-[(2S,4R,6S)-2-(4-hydroxyphenyl)-6-[2-(4-hydroxyphenyl)ethyl]oxan-4-yl]-5-methoxy-2,3-dihydrochromen-4-one
Synonyms:   Calyxin K; Epicalyxin K
Standard InCHIKey:  JHPJOKVLYIDVMB-DXOCUVQASA-N
Standard InCHI:  InChI=1S/C35H34O8/c1-41-32-19-28(39)33(35-34(32)29(40)18-31(43-35)22-7-13-26(38)14-8-22)23-16-27(15-4-20-2-9-24(36)10-3-20)42-30(17-23)21-5-11-25(37)12-6-21/h2-3,5-14,19,23,27,30-31,36-39H,4,15-18H2,1H3/t23-,27+,30+,31?/m1/s1
SMILES:  COc1cc(c([C@@H]2C[C@H](CCc3ccc(cc3)O)O[C@@H](C2)c2ccc(cc2)O)c2c1C(=O)CC(c1ccc(cc1)O)O2)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL455334
PubChem CID:   10348279
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002650] Diarylheptanoids
        • [CHEMONTID:0002651] Linear diarylheptanoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota seeds Mengha, Yunnan Province, China 1991-Aug PMID[11277741]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota seeds n.a. n.a. PMID[11325233]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota Seeds n.a. n.a. PMID[11430002]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota n.a. n.a. n.a. PMID[9461664]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO6836 Alpinia blepharocalyx Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT453 Cell Line HT-1080 Homo sapiens ED50 = 5.09 uM PMID[531536]
NPT453 Cell Line HT-1080 Homo sapiens ED50 = 4.75 uM PMID[531537]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 = 7.73 uM PMID[531536]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 = 33.0 uM PMID[531537]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC1796 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9933 High Similarity NPC51247
0.9868 High Similarity NPC42965
0.9868 High Similarity NPC226462
0.9868 High Similarity NPC98023
0.9867 High Similarity NPC257166
0.9801 High Similarity NPC15815
0.9799 High Similarity NPC121568
0.9737 High Similarity NPC195136
0.9735 High Similarity NPC475184
0.9733 High Similarity NPC37253
0.9733 High Similarity NPC79375
0.9671 High Similarity NPC105584
0.9669 High Similarity NPC69531
0.9664 High Similarity NPC178484
0.9613 High Similarity NPC473010
0.961 High Similarity NPC473012
0.9608 High Similarity NPC121647
0.9605 High Similarity NPC322459
0.9605 High Similarity NPC318527
0.9605 High Similarity NPC324358
0.9605 High Similarity NPC208258
0.9605 High Similarity NPC323627
0.9605 High Similarity NPC287789
0.9605 High Similarity NPC271741
0.9603 High Similarity NPC300668
0.9603 High Similarity NPC134171
0.96 High Similarity NPC115601
0.96 High Similarity NPC78324
0.96 High Similarity NPC208011
0.96 High Similarity NPC39154
0.9548 High Similarity NPC473009
0.9545 High Similarity NPC301256
0.9545 High Similarity NPC312273
0.9542 High Similarity NPC51760
0.9539 High Similarity NPC198489
0.9539 High Similarity NPC32867
0.9539 High Similarity NPC61112
0.953 High Similarity NPC3642
0.9474 High Similarity NPC258474
0.9474 High Similarity NPC201227
0.9474 High Similarity NPC66441
0.9474 High Similarity NPC182555
0.947 High Similarity NPC43345
0.947 High Similarity NPC174086
0.9463 High Similarity NPC122894
0.9427 High Similarity NPC251336
0.9416 High Similarity NPC295090
0.9412 High Similarity NPC56049
0.9412 High Similarity NPC309648
0.9412 High Similarity NPC54830
0.9408 High Similarity NPC324447
0.9404 High Similarity NPC476551
0.9404 High Similarity NPC476552
0.9404 High Similarity NPC476553
0.94 High Similarity NPC132345
0.94 High Similarity NPC473016
0.9396 High Similarity NPC475348
0.9396 High Similarity NPC261271
0.9346 High Similarity NPC215203
0.9346 High Similarity NPC186227
0.9346 High Similarity NPC52611
0.9346 High Similarity NPC265624
0.9346 High Similarity NPC14606
0.9346 High Similarity NPC159707
0.9346 High Similarity NPC100049
0.9346 High Similarity NPC158027
0.9346 High Similarity NPC121649
0.9346 High Similarity NPC248739
0.9346 High Similarity NPC150908
0.9346 High Similarity NPC205026
0.9333 High Similarity NPC152233
0.9329 High Similarity NPC470132
0.9329 High Similarity NPC470134
0.9329 High Similarity NPC228779
0.9329 High Similarity NPC470131
0.9329 High Similarity NPC473078
0.9329 High Similarity NPC470133
0.9329 High Similarity NPC109183
0.9299 High Similarity NPC63438
0.9281 High Similarity NPC71061
0.9281 High Similarity NPC290830
0.9281 High Similarity NPC303485
0.9281 High Similarity NPC194593
0.9281 High Similarity NPC72425
0.9276 High Similarity NPC148945
0.9276 High Similarity NPC316960
0.9276 High Similarity NPC204561
0.9276 High Similarity NPC78835
0.9276 High Similarity NPC317715
0.9276 High Similarity NPC309512
0.9262 High Similarity NPC282957
0.9262 High Similarity NPC473014
0.9262 High Similarity NPC194949
0.9262 High Similarity NPC271288
0.9262 High Similarity NPC470136
0.9262 High Similarity NPC470135
0.9262 High Similarity NPC235217
0.9262 High Similarity NPC39045
0.9236 High Similarity NPC15374
0.9236 High Similarity NPC473011
0.9205 High Similarity NPC145467
0.92 High Similarity NPC285630
0.92 High Similarity NPC127059
0.9195 High Similarity NPC185276
0.9195 High Similarity NPC81697
0.9195 High Similarity NPC223812
0.9195 High Similarity NPC107177
0.9195 High Similarity NPC125894
0.9195 High Similarity NPC77794
0.9195 High Similarity NPC85162
0.9195 High Similarity NPC278249
0.9193 High Similarity NPC477529
0.9182 High Similarity NPC224851
0.9172 High Similarity NPC175513
0.9172 High Similarity NPC114652
0.9172 High Similarity NPC18380
0.9167 High Similarity NPC90497
0.9167 High Similarity NPC55443
0.9167 High Similarity NPC18699
0.9167 High Similarity NPC195167
0.9167 High Similarity NPC123544
0.915 High Similarity NPC67322
0.915 High Similarity NPC209142
0.915 High Similarity NPC111112
0.915 High Similarity NPC312549
0.915 High Similarity NPC222713
0.915 High Similarity NPC138299
0.9145 High Similarity NPC291746
0.9145 High Similarity NPC288840
0.9139 High Similarity NPC300988
0.9139 High Similarity NPC296998
0.9139 High Similarity NPC308200
0.9139 High Similarity NPC10990
0.9139 High Similarity NPC283234
0.9139 High Similarity NPC473077
0.9136 High Similarity NPC168789
0.9133 High Similarity NPC471473
0.9133 High Similarity NPC236766
0.9133 High Similarity NPC131579
0.9133 High Similarity NPC473013
0.9133 High Similarity NPC197252
0.9133 High Similarity NPC471524
0.9133 High Similarity NPC473015
0.9133 High Similarity NPC471523
0.9133 High Similarity NPC131568
0.9128 High Similarity NPC1089
0.9128 High Similarity NPC78
0.9128 High Similarity NPC328164
0.9128 High Similarity NPC220998
0.9128 High Similarity NPC228504
0.9128 High Similarity NPC265040
0.9128 High Similarity NPC32739
0.9128 High Similarity NPC227579
0.9128 High Similarity NPC324436
0.9128 High Similarity NPC223500
0.9128 High Similarity NPC66515
0.9128 High Similarity NPC324134
0.9128 High Similarity NPC37496
0.9128 High Similarity NPC182852
0.9128 High Similarity NPC161506
0.9128 High Similarity NPC107572
0.9128 High Similarity NPC166482
0.9128 High Similarity NPC76338
0.9128 High Similarity NPC40833
0.9128 High Similarity NPC306829
0.9128 High Similarity NPC177354
0.9128 High Similarity NPC296917
0.9128 High Similarity NPC76372
0.9128 High Similarity NPC166934
0.9128 High Similarity NPC125855
0.9128 High Similarity NPC64915
0.9128 High Similarity NPC194432
0.9128 High Similarity NPC10937
0.9128 High Similarity NPC148757
0.9128 High Similarity NPC167624
0.9108 High Similarity NPC292863
0.9108 High Similarity NPC184326
0.9085 High Similarity NPC29777
0.9085 High Similarity NPC471115
0.9079 High Similarity NPC132592
0.9079 High Similarity NPC161191
0.9079 High Similarity NPC39195
0.9079 High Similarity NPC160821
0.9073 High Similarity NPC470647
0.9073 High Similarity NPC474161
0.9073 High Similarity NPC246948
0.9073 High Similarity NPC83357
0.9073 High Similarity NPC142405
0.9073 High Similarity NPC176229
0.9073 High Similarity NPC476088
0.9073 High Similarity NPC477955
0.9073 High Similarity NPC88964
0.9073 High Similarity NPC20488
0.9073 High Similarity NPC111786
0.9073 High Similarity NPC267375
0.9073 High Similarity NPC301276
0.9073 High Similarity NPC214774
0.9073 High Similarity NPC195621
0.9073 High Similarity NPC472629
0.9073 High Similarity NPC475052

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC1796 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9603 High Similarity NPD8443 Clinical (unspecified phase)
0.9172 High Similarity NPD6959 Discontinued
0.9119 High Similarity NPD7852 Clinical (unspecified phase)
0.8917 High Similarity NPD7768 Phase 2
0.8903 High Similarity NPD7411 Suspended
0.8882 High Similarity NPD7410 Clinical (unspecified phase)
0.8792 High Similarity NPD1552 Clinical (unspecified phase)
0.8792 High Similarity NPD1550 Clinical (unspecified phase)
0.879 High Similarity NPD7819 Suspended
0.8758 High Similarity NPD4378 Clinical (unspecified phase)
0.8742 High Similarity NPD7075 Discontinued
0.8733 High Similarity NPD1549 Phase 2
0.872 High Similarity NPD7804 Clinical (unspecified phase)
0.8718 High Similarity NPD4380 Phase 2
0.8671 High Similarity NPD2393 Clinical (unspecified phase)
0.865 High Similarity NPD6168 Clinical (unspecified phase)
0.865 High Similarity NPD6167 Clinical (unspecified phase)
0.865 High Similarity NPD6166 Phase 2
0.8553 High Similarity NPD7096 Clinical (unspecified phase)
0.8477 Intermediate Similarity NPD2796 Approved
0.8411 Intermediate Similarity NPD1510 Phase 2
0.8395 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8375 Intermediate Similarity NPD1934 Approved
0.8333 Intermediate Similarity NPD7074 Phase 3
0.8293 Intermediate Similarity NPD5494 Approved
0.8282 Intermediate Similarity NPD3749 Approved
0.8274 Intermediate Similarity NPD7054 Approved
0.8267 Intermediate Similarity NPD1240 Approved
0.8261 Intermediate Similarity NPD6801 Discontinued
0.8255 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8225 Intermediate Similarity NPD7472 Approved
0.8194 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD7808 Phase 3
0.8176 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8158 Intermediate Similarity NPD1607 Approved
0.8155 Intermediate Similarity NPD7473 Discontinued
0.814 Intermediate Similarity NPD8312 Approved
0.814 Intermediate Similarity NPD8313 Approved
0.8129 Intermediate Similarity NPD7251 Discontinued
0.8121 Intermediate Similarity NPD4908 Phase 1
0.811 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8101 Intermediate Similarity NPD7390 Discontinued
0.807 Intermediate Similarity NPD6797 Phase 2
0.8039 Intermediate Similarity NPD6651 Approved
0.8025 Intermediate Similarity NPD3750 Approved
0.7988 Intermediate Similarity NPD2801 Approved
0.7988 Intermediate Similarity NPD8455 Phase 2
0.7987 Intermediate Similarity NPD1511 Approved
0.7987 Intermediate Similarity NPD6799 Approved
0.7976 Intermediate Similarity NPD6232 Discontinued
0.7962 Intermediate Similarity NPD2800 Approved
0.7953 Intermediate Similarity NPD5844 Phase 1
0.7919 Intermediate Similarity NPD6559 Discontinued
0.7914 Intermediate Similarity NPD6599 Discontinued
0.7898 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7892 Intermediate Similarity NPD3882 Suspended
0.7888 Intermediate Similarity NPD1512 Approved
0.7874 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD5403 Approved
0.7831 Intermediate Similarity NPD3817 Phase 2
0.7821 Intermediate Similarity NPD2799 Discontinued
0.7821 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD3818 Discontinued
0.7771 Intermediate Similarity NPD1551 Phase 2
0.7771 Intermediate Similarity NPD6100 Approved
0.7771 Intermediate Similarity NPD6099 Approved
0.7759 Intermediate Similarity NPD5953 Discontinued
0.7747 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD7458 Discontinued
0.7735 Intermediate Similarity NPD4363 Phase 3
0.7735 Intermediate Similarity NPD4360 Phase 2
0.7722 Intermediate Similarity NPD2344 Approved
0.7716 Intermediate Similarity NPD2534 Approved
0.7716 Intermediate Similarity NPD2533 Approved
0.7716 Intermediate Similarity NPD2532 Approved
0.7716 Intermediate Similarity NPD5401 Approved
0.7716 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7709 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7707 Intermediate Similarity NPD3748 Approved
0.767 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD2935 Discontinued
0.7651 Intermediate Similarity NPD1610 Phase 2
0.7644 Intermediate Similarity NPD7286 Phase 2
0.7636 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7636 Intermediate Similarity NPD3226 Approved
0.7625 Intermediate Similarity NPD1243 Approved
0.7622 Intermediate Similarity NPD920 Approved
0.7619 Intermediate Similarity NPD5402 Approved
0.7595 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7579 Intermediate Similarity NPD8151 Discontinued
0.7578 Intermediate Similarity NPD7003 Approved
0.7578 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD4628 Phase 3
0.7545 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7533 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD6832 Phase 2
0.7531 Intermediate Similarity NPD2309 Approved
0.7516 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD5124 Phase 1
0.75 Intermediate Similarity NPD7698 Approved
0.75 Intermediate Similarity NPD7697 Approved
0.75 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7696 Phase 3
0.7469 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.746 Intermediate Similarity NPD7871 Phase 2
0.746 Intermediate Similarity NPD7870 Phase 2
0.7457 Intermediate Similarity NPD7229 Phase 3
0.7456 Intermediate Similarity NPD1465 Phase 2
0.7438 Intermediate Similarity NPD5406 Approved
0.7438 Intermediate Similarity NPD5405 Approved
0.7438 Intermediate Similarity NPD5408 Approved
0.7438 Intermediate Similarity NPD5404 Approved
0.7436 Intermediate Similarity NPD3268 Approved
0.7436 Intermediate Similarity NPD2313 Discontinued
0.7414 Intermediate Similarity NPD3926 Phase 2
0.7409 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7409 Intermediate Similarity NPD7783 Phase 2
0.7405 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD4361 Phase 2
0.7403 Intermediate Similarity NPD2798 Approved
0.7403 Intermediate Similarity NPD8150 Discontinued
0.7391 Intermediate Similarity NPD2346 Discontinued
0.7375 Intermediate Similarity NPD7033 Discontinued
0.7356 Intermediate Similarity NPD3787 Discontinued
0.7344 Intermediate Similarity NPD7701 Phase 2
0.734 Intermediate Similarity NPD6777 Approved
0.734 Intermediate Similarity NPD6780 Approved
0.734 Intermediate Similarity NPD6779 Approved
0.734 Intermediate Similarity NPD6781 Approved
0.734 Intermediate Similarity NPD6782 Approved
0.734 Intermediate Similarity NPD6776 Approved
0.734 Intermediate Similarity NPD6778 Approved
0.734 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD2797 Approved
0.7338 Intermediate Similarity NPD1203 Approved
0.7322 Intermediate Similarity NPD4287 Approved
0.7316 Intermediate Similarity NPD7435 Discontinued
0.7305 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD7199 Phase 2
0.7294 Intermediate Similarity NPD7577 Discontinued
0.7292 Intermediate Similarity NPD7584 Approved
0.7289 Intermediate Similarity NPD7447 Phase 1
0.7289 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD3751 Discontinued
0.7288 Intermediate Similarity NPD7228 Approved
0.7288 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7288 Intermediate Similarity NPD7177 Discontinued
0.7283 Intermediate Similarity NPD919 Approved
0.7267 Intermediate Similarity NPD1548 Phase 1
0.7261 Intermediate Similarity NPD4625 Phase 3
0.7257 Intermediate Similarity NPD5711 Approved
0.7257 Intermediate Similarity NPD5710 Approved
0.7253 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD6273 Approved
0.7234 Intermediate Similarity NPD7700 Phase 2
0.7234 Intermediate Similarity NPD7699 Phase 2
0.7233 Intermediate Similarity NPD943 Approved
0.7231 Intermediate Similarity NPD7801 Approved
0.7229 Intermediate Similarity NPD7212 Phase 2
0.7229 Intermediate Similarity NPD7213 Phase 3
0.7216 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD6798 Discontinued
0.7215 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7213 Intermediate Similarity NPD8434 Phase 2
0.7205 Intermediate Similarity NPD7097 Phase 1
0.72 Intermediate Similarity NPD1247 Approved
0.7188 Intermediate Similarity NPD6355 Discontinued
0.7188 Intermediate Similarity NPD8319 Approved
0.7188 Intermediate Similarity NPD8320 Phase 1
0.7179 Intermediate Similarity NPD7874 Approved
0.7179 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7173 Intermediate Similarity NPD6823 Phase 2
0.7151 Intermediate Similarity NPD5760 Phase 2
0.7151 Intermediate Similarity NPD5761 Phase 2
0.7143 Intermediate Similarity NPD1608 Approved
0.7143 Intermediate Similarity NPD9717 Approved
0.7134 Intermediate Similarity NPD2861 Phase 2
0.7125 Intermediate Similarity NPD1613 Approved
0.7125 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD3267 Approved
0.7115 Intermediate Similarity NPD3266 Approved
0.7111 Intermediate Similarity NPD1729 Discontinued
0.711 Intermediate Similarity NPD4288 Approved
0.7107 Intermediate Similarity NPD3764 Approved
0.7097 Intermediate Similarity NPD4749 Approved
0.7093 Intermediate Similarity NPD6844 Discontinued
0.7093 Intermediate Similarity NPD37 Approved
0.7091 Intermediate Similarity NPD2654 Approved
0.7086 Intermediate Similarity NPD6234 Discontinued
0.7078 Intermediate Similarity NPD422 Phase 1
0.7078 Intermediate Similarity NPD1201 Approved
0.7074 Intermediate Similarity NPD6534 Approved
0.7074 Intermediate Similarity NPD6535 Approved
0.7069 Intermediate Similarity NPD4965 Approved
0.7069 Intermediate Similarity NPD4966 Approved
0.7069 Intermediate Similarity NPD4967 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data